High ROIC Stocks
LLY is currently part of our High ROIC Stocks screen, indicating it generates strong returns on invested capital.
ELI LILLY & CO (LLY) Stock Price & Overview
NYSE:LLY • US5324571083
Current stock price
963.33 USD
+28.73 (+3.07%)
At close:
961.839 USD
-1.49 (-0.15%)
After Hours:
The current stock price of LLY is 963.33 USD. Today LLY is up by 3.07%. In the past month the price increased by 2.97%. In the past year, price increased by 16.96%.
LLY Key Statistics
52-Week Range623.78 - 1133.95
Current LLY stock price positioned within its 52-week range.
1-Month Range850.51 - 984.45
Current LLY stock price positioned within its 1-month range.
- Market Cap
- 910.173B
- P/E
- 32.74
- Fwd P/E
- 22.63
- EPS (TTM)
- 29.42
- Dividend Yield
- 0.74%
LLY Stock Performance
Today
+3.07%
1 Week
+8.98%
1 Month
+2.97%
3 Months
-7.12%
Longer-term
6 Months +11.64%
1 Year +16.96%
2 Years +17.43%
3 Years +124.31%
5 Years +382.29%
10 Years +1,183.93%
LLY Stock Chart
LLY Stock Screens
LLY currently appears in the following ChartMill screener lists.
Fastest Growing Stocks
LLY is part of our fastest growing stocks screen, indicating it has high EPS and sales growth.
Revenue Growth Leaders
LLY is part of our revenue growth leaders stock screen, indicating it has strong recent and multi-year revenue growth.
High EPS Growth Stocks
LLY occurs in our High EPS Growth Stocks screen list, indicating it is profitable, healthy and showing strong recent EPS growth.
LLY Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to LLY. When comparing the yearly performance of all stocks, LLY turns out to be only a medium performer in the overall market: it outperformed 48.78% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
LLY Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to LLY. LLY scores excellent on profitability, but there are some minor concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
LLY Earnings
On April 30, 2026 LLY reported an EPS of 8.55 and a revenue of 19.80B. The company beat EPS expectations (26.97% surprise) and beat revenue expectations (11.04% surprise).
Next Earnings DateAug 5, 2026
Last Earnings DateApr 30, 2026
PeriodQ1 / 2026
EPS Reported$8.55
Revenue Reported19.799B
EPS Surprise 26.97%
Revenue Surprise 11.04%
LLY Forecast & Estimates
39 analysts have analysed LLY and the average price target is 1218.78 USD. This implies a price increase of 26.52% is expected in the next year compared to the current price of 963.33.
For the next year, analysts expect an EPS growth of 44.42% and a revenue growth 28.55% for LLY
Analysts
Analysts81.03
Price Target1218.78 (26.52%)
EPS Next Y44.42%
Revenue Next Year28.55%
LLY Index Membership
LLY is currently included in the following stock indexes tracked on ChartMill.
LLY Financial Highlights
Over the last trailing twelve months LLY reported a non-GAAP Earnings per Share(EPS) of 29.42. The EPS increased by 113.81% compared to the year before.
Income Statements
Revenue(TTM)72.25B
Net Income(TTM)25.28B
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 34.99% | ||
| ROA | 21.68% | ||
| ROE | 81.02% | ||
| Debt/Equity | 1.32 |
Chartmill High Growth Momentum
EPS Q2Q%155.99%
Sales Q2Q%55.55%
EPS 1Y (TTM)113.81%
Revenue 1Y (TTM)47.44%
LLY Ownership
Ownership
Inst Owners84.43%
Shares944.82M
Float942.60M
Ins Owners0.16%
Short Float %0.86%
Short Ratio2.78
LLY Industry Overview
LLY operates in the Pharmaceuticals sub-industry within the Health Care sector. This group contains 135 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Strength Score
67/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
Industry Growth Score
16/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
47%
Outperformed 47% of sub-industries
3 Month Rank
55%
Outperformed 55% of sub-industries
6 Month Rank
42%
Outperformed 42% of sub-industries
Industry Fundamentals & Breadth
- Members
- 135
- New Highs
- 5.2%
- New Lows
- 3%
- Average ROE
- 96.3%
- Average Profit Margin
- 29.8%
- Average Operating Margin
- 41.4%
- Average P/E
- 25.7
- Average Fwd P/E
- 17.8
- Average Debt/Equity
- 1.3
LLY Latest News, Press Relases and Analysis
4 days ago - By: Chartmill
14 days ago - By: Chartmill
16 days ago - By: Chartmill
LLY Competitors/Peers
The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | 17.91 | 547.212B | ||
| MRK | MERCK & CO. INC. | 11.43 | 277.022B | ||
| PFE | PFIZER INC | 8.81 | 149.775B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.41 | 118.87B | ||
| ZTS | ZOETIS INC | 16.14 | 48.007B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.57 | 28.541B | ||
| VTRS | VIATRIS INC | 6.03 | 17.513B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.39 | 11.241B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 10.564B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 6.109B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.809B | ||
| CORT | CORCEPT THERAPEUTICS INC | 35.54 | 5.47B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About LLY
Company Profile
The company is headquartered in Indianapolis, Indiana and currently employs 50,000 full-time employees.
Company Info
IPO: 1970-07-09
ELI LILLY & CO
Lilly Corporate Ctr, Drop Code 1094
Indianapolis INDIANA 46285 US
CEO: David A. Ricks
Employees: 50000
Phone: 13172762000
ELI LILLY & CO / LLY FAQ
Can you describe the business of ELI LILLY & CO?
The company is headquartered in Indianapolis, Indiana and currently employs 50,000 full-time employees.
What is the stock price of ELI LILLY & CO today?
The current stock price of LLY is 963.33 USD. The price increased by 3.07% in the last trading session.
Does ELI LILLY & CO pay dividends?
ELI LILLY & CO (LLY) has a dividend yield of 0.74%. The yearly dividend amount is currently 5.69.
How is the ChartMill rating for ELI LILLY & CO?
LLY has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What do analysts say about ELI LILLY & CO (LLY) stock?
39 analysts have analysed LLY and the average price target is 1218.78 USD. This implies a price increase of 26.52% is expected in the next year compared to the current price of 963.33.
Is ELI LILLY & CO (LLY) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LLY.
Can you provide the market cap for ELI LILLY & CO?
ELI LILLY & CO (LLY) has a market capitalization of 910.17B USD. This makes LLY a Mega Cap stock.